QUIDEL CORP /DE/
10-Q, EX-27.1, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: QUIDEL CORP /DE/, 10-Q, EX-10.2, 2000-08-14
Next: NESS ENERGY INTERNATIONAL INC /NV/, NT 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF QUIDEL'S FORM 10-Q FOR THE PERIOD
ENDED JUNE 30, 2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           5,917
<SECURITIES>                                         0
<RECEIVABLES>                                   14,157
<ALLOWANCES>                                     1,435
<INVENTORY>                                      8,673
<CURRENT-ASSETS>                                28,892
<PP&E>                                          40,447
<DEPRECIATION>                                  19,289
<TOTAL-ASSETS>                                  69,859
<CURRENT-LIABILITIES>                           10,934
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            25
<OTHER-SE>                                      47,600
<TOTAL-LIABILITY-AND-EQUITY>                    69,859
<SALES>                                         39,032
<TOTAL-REVENUES>                                39,703
<CGS>                                           19,022
<TOTAL-COSTS>                                   36,656
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 621
<INCOME-PRETAX>                                  2,068
<INCOME-TAX>                                       827
<INCOME-CONTINUING>                              1,241
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,241
<EPS-BASIC>                                        .05
<EPS-DILUTED>                                      .05


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission